Skip to content
10-Q

Quarterly Report

BIOSTEM U.S. CORP

0001477932-12-003932

← back to feed
Filed
Oct 19, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Oct 19, 2012 273.37M sh
Operating Cash Flow Q2 2012 · Aug 31, 2012 −$302.84K
Operating Cash Flow Q2 2012 · Aug 31, 2011 −$367.24K
Stockholders Equity Q2 2012 · Aug 31, 2012 −$589.22K
Stockholders Equity Q2 2012 · Feb 29, 2012 −$74.41K
Current Liabilities Q2 2012 · Aug 31, 2012 $590.58K
Current Liabilities Q2 2012 · Feb 29, 2012 $90.32K
Current Assets Q2 2012 · Aug 31, 2012 $1.36K
Current Assets Q2 2012 · Feb 29, 2012 $15.9K
Total Assets Q2 2012 · Aug 31, 2012 $1.36K
Total Assets Q2 2012 · Feb 29, 2012 $15.9K
Sga Expense Q2 2012 · Aug 31, 2012 $2.11M
Sga Expense Q2 2012 · Aug 31, 2012 $3M
Sga Expense Q2 2012 · Aug 31, 2011 $1.3M
Sga Expense Q2 2012 · Aug 31, 2011 $1.51M
Net Income Q2 2012 · Aug 31, 2012 −$2.12M
Net Income Q2 2012 · Aug 31, 2012 −$3.01M
Net Income Q2 2012 · Aug 31, 2011 −$1.29M
Net Income Q2 2012 · Aug 31, 2011 −$1.46M
Gross Profit Q2 2012 · Aug 31, 2012 −$303
Gross Profit Q2 2012 · Aug 31, 2012 $321
Gross Profit Q2 2012 · Aug 31, 2011 $5.68K
Gross Profit Q2 2012 · Aug 31, 2011 $54.92K
Cost Of Revenue Q2 2012 · Aug 31, 2012 $423
Cost Of Revenue Q2 2012 · Aug 31, 2012 $423
Cost Of Revenue Q2 2012 · Aug 31, 2011 $54
Cost Of Revenue Q2 2012 · Aug 31, 2011 $38.49K
Revenue Q2 2012 · Aug 31, 2012 $120
Revenue Q2 2012 · Aug 31, 2012 $744
Revenue Q2 2012 · Aug 31, 2011 $5.74K
Revenue Q2 2012 · Aug 31, 2011 $93.41K